March 24, 2020

The U.S. Food and Drug Administration (FDA), on March 23, announced the following actions in its ongoing response effort to the COVID-19 pandemic: • The FDA issued a safety alert for fecal microbiota transplantation (FMT) procedures. The FDA has issued […]

March 24, 2020

Astellas Pharma plans to expand its pipeline of next-gen immuno-oncology treatments through a collaboration with CytomX that could generate more than $1.68 billion for the South San Francisco, CA, developer of antibody therapeutics. Through the collaboration, announced Monday night, Astellas […]

March 23, 2020

Fake in-home test kits for coronavirus are being marketed in the United States and could pose serious health risks, the U.S. Food and Drug Administration says. “We want to alert the American public that, at this time, the FDA has […]

March 23, 2020

Compassionate use, as Gilead noted in its Sunday statement, was not designed to facilitate widespread access to experimental drugs during a public health emergency. So far, the biotech has provided remdesivir to “several hundred” patients sick with COVID-19 in the […]

March 20, 2020

As the biotech industry tries to match the pace of the pandemic with its own research response, we at FierceBiotech are rounding up the industry’s attempts to combat the virus after infection. As this is a rapidly moving situation, we […]